Clinical trials recruiting for ALS (Amyotrophic Lateral Sclerosis)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| LY4256984 | 1 |
| Psilocybin therapy | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Massachusetts | 2 |
| Pennsylvania | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
- ALS Research Collaborative
- Biofluid Research on Age-Related or Inherited Neurodegeneration
- Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
- Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
- Invasive Home Ventilation in Denmark
- Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases
- Psilocybin Therapy for Psychological Distress in Palliative Patients
- The Swedish BioFINDER 2 Study
- Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
Related conditions
Trials recruiting for ALS (Amyotrophic Lateral Sclerosis) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for ALS (Amyotrophic Lateral Sclerosis) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.